Pharmaceutical stakeholders target draft guidelines for announced drug pricing regulations
The changes to the regulations governing the Patented Medicine Prices Review Board (PMPRB) were released Aug. 9. The PMPRB will begin consultations on new draft guidelines for the regulations this fall. (Pixabay photo)
This content is available to lobbymonitor.ca subscribers.
Already a subscriber?
Sign in here
The Lobby Monitor community is passionate, plugged-in and engaged in Canadian politics and policy.
Come inside the bubble. Take a free trial today.
Free Trial
